Vaccination with tumor peptide in CpG adjuvant protects via IFN-γ-dependent CD4 cell immunity

Journal of Immunology

Volumn 168, Issue 12, 2002, Pages 6099-6105

  Stern, Britta V ^a   Boehm, Bernhard O ^a   Tary Lehmann, Magdalena ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OLIGONUCLEOTIDE; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; CYTOTOXICITY; FEMALE; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENICITY; KNOCKOUT MOUSE; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR GROWTH; TUMOR IMMUNITY; VACCINATION;

EID: 0037097633     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.12.6099     Document Type: Article

References (24)

1. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
2. The mode of action of mineral-oil emulsion adjuvants on antibody production in mice
3. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity
4. Adjuvant-guided type-1 and type-2 immunity: Infectious/noninfectious dichotomy defines the class of response
5. Use of CpG DNA for enhancing specific immune responses
6. Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides
7. CpG DNA in cancer immunotherapy
8. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
9. Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA
10. The role of CpG dinucleotides in DNA vaccines
11. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
12. Bacterial CpG DNA activates immune cells to signal infectious danger
13. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
14. Host resistance directed selectively against H-2-deficient lymphoma variants: Analysis of the mechanism
15. DO1.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope
16. + T cell clones
17. Indirect IL-4 pathway in type 1 immunity
18. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
19. Pathways of O-glycan biosynthesis in cancer cells
20. Phylogenetic perspectives in innate immunity
21. Acute lethal graft-versus-host reaction induced by major histocompatibility complex class II-reactive T helper cell clones
22. + T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN γ receptor expression by nonhematopoietic cells
23. The contribution of peptides to T cell allorecognition and allograft rejection
24. Determinant spreading and the dynamics of the autoimmune T-cell repertoire